As mentioned earlier, a recent research breakthrough on lipid NPs encapsulating siRNA was the 21 base pairs siRNA drug patisiran to treat TTR amyloidosis, a multisystemic disease causes by misfolded TTR, that affects nerves, heart, and the gastrointestinal tract (Adams et al., 2017). Here, TTR is linked to amyloidosis.